VIDAS® D-Dimer Exclusion II ™ 30455-01Recalls & reported problems
Biomerieux SA · VIDAS ® D-Dimer Exclusion II™ is an automated quantitative test for use on the VIDAS instruments indicated for use in conjunction with a clinical model to exclude DVT and PE. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 03573026387006), received between Aug 26, 2019 and Jan 15, 2021 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
3 other recalls cover devices cleared under the same FDA submission (K141133); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Sep 22, 2021Class IIOpen, Classified
bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.
Z-0427-2022 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings2
Patient problems
- No Patient Involvement2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 15, 2021Incorrect, Inadequate or Imprecise Result or Readings
A CUSTOMER IN THE UNITED STATES NOTIFIED BIOMERIEUX OF OBTAINING UNDERESTIMATED RESULTS WHEN TESTING AN EXTERNAL QUALITY CONTROL SAMPLE USING THEIR VIDAS® 3 INSTRUMENT (REF. 414356, SERIAL NUMBER (B)(4)) AND VIDAS® D DIMER EXCLUS II 60T US TEST KIT (REF. 30455-01). THE LOT NUMBER FOR THE ASSAY WAS NOT PROVIDED. THE CUSTOMER OBTAINED RESULTS BETWEEN 1-2 STANDARD DEVIATIONS BELOW THE EXPECTED RESULT ACCORDING TO QC NET. AS THERE IS NO PATIENT ASSOCIATED WITH THIS QUALITY CONTROL STRAIN, THERE IS NO ADVERSE EVENT RELATED TO ANY PATIENT'S STATE OF HEALTH. BIOMERIUEX CUSTOMER SERVICE ATTEMPTED TO CONTACT THE CUSTOMER TO OBTAIN LAB REPORTS AND IMPACTED LOT NUMBERS; TO DATE THE CUSTOMER HAS NOT PROVIDED A RESPONSE. IT IS CURRENTLY UNKNOWN IF THE UNDERESTIMATED RESULTS OBTAINED BY THE CUSTOMER RESULTED IN AN INTERPRETATION CHANGE OF THE RESULTS. THE CUSTOMER ALSO TESTED AN EXTERNAL QUALITY CONTROL PROCALCITONIN SAMPLE USING THEIR VIDAS® 3 INSTRUMENT (REF. 414356, SERIAL NUMBER (B)(4)) AND OBTAINED PASSING RESULTS. BIOMERIEUX WILL INITIATE AN INTERNAL INVESTIGATION.
Patient problems: No Patient Involvement
MAUDE report 11181548 ↗MalfunctionAug 26, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
A CUSTOMER IN THE UNITED STATES REPORTED OUT OF RANGE LOW RESULTS FOR PROFICIENCY SAMPLES FROM THE AMERICAN PROFICIENCY INSTITUTE (API) IN ASSOCIATION WITH THE VIDAS® D DIMER EXCLUSION¿ II ASSAY. THE CUSTOMER REPORTED THE CARDIAC MARKER TEST OF SAMPLES CM-06 AND CM-08 FOR THE D-DIMER RECEIVED A GRADE OF UNACCEPTABLE (60%). THE EXPECTED RESULT FOR SAMPLE CM-06 WAS 0.375-0.543UG FEU/ML AND THE CUSTOMER REPORTED 0.374UG FEU/ML. THE EXPECTED RESULT FOR SAMPLE CM-08 WAS 1.388-1.987UG FEU/ML AND THE CUSTOMER REPORTED 1.364UG FEU/ML. THE SAMPLES WERE REPEATED WITH A DIFFERENT STRIP LOT AND WERE IN RANGE, IN WHICH SAMPLE CM-06 WAS 0.471UG FEU/ML. AND CM-08 WAS 1.678UG FEU/ML. THERE WAS NO PATIENT INVOLVEMENT AS THE EVENT PERTAINED TO A PROFICIENCY SAMPLE. A BIOMÉRIEUX INTERNAL INVESTIGATION WILL BE INITIATED.
Patient problems: No Patient Involvement
MAUDE report 8933393 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K141133. One submission often covers many models, so check the product and lot details in each record.
- Z-0797-2023 · Nov 9, 2022 · Open, ClassifiedVIDAS CLINICAL VIDAS RUB IGG 60 TESTS, CATALOG 30226
- Z-0864-2023 · Nov 9, 2022 · Open, ClassifiedVIDAS CLINICAL VIDAS HCG 60 TESTS, CATALOG 30405-01
- Z-0928-2020 · Oct 22, 2019 · TerminatedBIOMERIEUX VIDAS 3, Compact immunoanalyzer with full traceability and automation
Other Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control devices
- STA® - Liatest® D-Di 00515Diagnostica Stago · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL2 recalls0 reports
- INNOVANCE® D-Dimer 10445981Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL9 reports
- INNOVANCE® D-Dimer 10445982Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL8 reports
- Alere Triage® 98100Alere San Diego, Inc. · Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control4 reports
- INNOVANCE® D-Dimer Controls 10446006Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL2 reports
- Triage 98100Quidel Cardiovascular Inc. · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page